| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.18 | 0.6 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |